2cureX AB (publ) (STO:2CUREX)
Sweden · Delayed Price · Currency is SEK 2.000
-0.120 (-5.66%)
Jul 3, 2026, 5:22 PM CET
2cureX AB Market Cap
2cureX AB has a market cap or net worth of 63.81 million as of July 2, 2026. Its market cap has decreased by -25.68% in one year.
Market Cap
63.81M
Enterprise Value
n/a
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since November 24, 2017, 2cureX AB's market cap has decreased from 83.32M to 63.81M, a decrease of -23.42%. That is a compound annual growth rate of -3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 63.81M | 394.51% |
| Dec 30, 2025 | 12.90M | 73.70% |
| Dec 30, 2024 | 7.43M | -79.00% |
| Dec 29, 2023 | 35.38M | -75.34% |
| Dec 30, 2022 | 143.46M | -51.13% |
| Dec 30, 2021 | 293.59M | 19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 105.49M |
| Biovica International AB | 103.92M |
| OncoZenge AB | 103.82M |
| Spago Nanomedical AB | 92.61M |
| Scandinavian ChemoTech AB | 92.40M |
| Annexin Pharmaceuticals AB | 85.06M |
| AcouSort AB | 83.17M |
| Alzinova AB | 81.82M |